Publications
Specialty
Search
Oncology
10/23/2024
According to results from the updated analysis of the ShortHER trial, tumor-infiltrating lymphocyte score is predictive of overall survival and may potentially be used to guide trastuzumab de-escalation among patients with HER2-negative early breast cancer.
First Report Managed Care
10/23/2024
A decade-long study demonstrated that early treatment with ocrelizumab significantly reduces disability progression in patients with relapsing and primary progressive multiple sclerosis.
Journal of Invasive Cardiology, CardioVascular
10/23/2024
The authors describe a young population of patients with anomalous aortic origin of a coronary artery and myocardial bridge and review the safety of intravascular ultrasound in this population.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
10/23/2024
Tioga Cardiovascular, Inc., a Shifamed portfolio company, announced the first-in-human transseptal implantations using the 28 French) Luna™ transcatheter mitral valve replacement (TMVR) system. The first patients achieved excellent hemodynamics post procedure.
First Report Managed Care
10/23/2024
Black patients with multiple sclerosis experience higher rates of unplanned health care utilization and poorer mental health outcomes compared to their White counterparts, according to a study presented at the 2024 AAN Annual Meeting.
Oncology
10/23/2024
Andrea Necchi, MD, discusses results from the SunRISe-4 study which assessed the addition of TAR-200 to neoadjuvant cetrelimab in a cohort of patients with muscle-invasive bladder cancer who either refused or were ineligible for cisplatin-based chemotherapy.
First Report Managed Care
10/23/2024
Researchers analyzed Medicare Part D spending trends on disease-modifying therapies for multiple sclerosis and autoimmune neurological disorders from 2013 to 2021, revealing a significant increase in both claims and costs.
Vascular Disease Management, CardioVascular
10/23/2024
John Rundback, MD, spoke with VDM about his AMP 2024 presentation on a subgroup analysis of the PATHFINDER Registry, which is a prospective, nonrandomized, multicenter study that evaluated the performance and outcome of the Auryon laser atherectomy system.
Journal of Invasive Cardiology, CardioVascular
10/23/2024
The authors evaluated their experience with 2 distinct vascular closure device approaches using the Perclose ProGlide and the Angio-Seal, as well as the impact on vascular access site complications during transcatheter aortic valve replacement .
Oncology
10/23/2024
The TNBC-DX, a novel genomic test for patients with early-stage triple-negative breast cancer, was found to be effective at predicting a patient’s pCR and survival outcomes.
Oncology
10/23/2024
According to results from the phase 2 Neo-CheckRay trial, the addition of durvalumab and oleclumab to standard SBRT and neoadjuvant chemotherapy demonstrates promise among patients with ER-positive, HER2-negative, high-risk early breast cancer.
Annals of Long-Term Care
10/23/2024
Researchers investigated how immune cells in human epicardial adipose tissue (EAT) contribute to atrial fibrillation (AF), revealing a potential link between inflammation and cardiac arrhythmia according to research published in Nature Cardiovascular Research.
Pharmacy Learning Network
10/23/2024
The United States Department of Justice has announced the conviction of 4 pharmacy owners for conspiracy to commit health care fraud and wire fraud.
First Report Managed Care, Population Health
10/23/2024
With the 2024 elections just 13 days away, everyone has one question: What happens next? The stakes are particularly high for health policy, but there’s a cloud of uncertainty hanging over the predictions—especially when it comes to polling data. As we’ve seen in recent elections, polls don’t always tell the whole story. So, while health care and the economy are top concerns for voters, it’s unclear how this will play out once the votes are counted.
The Polling Puzzle
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
10/22/2024
Compared to white patients, Black patients were 22% more likely to die in the hospital. Black patients stayed in the hospital 1.5 days longer on average (9.6 days for white patients, 10.7 days for Hispanic patients and 11.8 days for Black patients). Black patients had a 23% higher rate of cardiac arrest. Total hospital costs were $23,000 higher for Black patients and $78,000 higher for Hispanic patients.
EMSWorld, Emergency & Mobile Medicine
10/22/2024
Oct. 21 news conference quantifies and promotes the use of prehospital whole blood delivery by EMS agencies nationwide.
Oncology
10/22/2024
This sponsored video presents the 10-year survival data of dabrafenib plus trametinib for patients with stage II BRAF V600E/K melanoma after surgery.
EMSWorld, Emergency & Mobile Medicine
10/22/2024
Nearly 70 studies show that boarding is associated with elevated health and safety risks, prolonged delays in treatment, and increased likelihood of death.
EMSWorld, Emergency & Mobile Medicine
NEMSQA Wins Nicholas Rosecrans Award for Reducing Ambulance Crashes with Lights and Siren Initiative
10/22/2024
The winners were recognized during the opening ceremonies at EMS World Expo in Las Vegas.
EMSWorld, Emergency & Mobile Medicine
10/22/2024
The department has delivered 139 units of blood to 133 patients so far.
Reimbursement Library From A to Z
Subscribe and never miss an article!
Today's Wound Clinic Newsletter
